DB:3H5

Stock Analysis Report

Thomson Medical Group

Executive Summary

Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore, Malaysia, the United Kingdom, China, the Middle East, and internationally.


Snowflake Analysis

Poor track record with worrying balance sheet.


Similar Companies

Share Price & News

How has Thomson Medical Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 3H5 has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

2.7%

3H5

1.6%

DE Healthcare

-0.9%

DE Market


1 Year Return

n/a

3H5

3.2%

DE Healthcare

12.8%

DE Market

Return vs Industry: Insufficient data to determine how 3H5 performed against the German Healthcare industry.

Return vs Market: Insufficient data to determine how 3H5 performed against the German Market.


Shareholder returns

3H5IndustryMarket
7 Day2.7%1.6%-0.9%
30 Day-5.0%4.8%0.6%
90 Day2.7%5.6%2.9%
1 Yearn/a5.0%3.2%16.3%12.8%
3 Yearn/a-19.4%-22.3%15.8%5.7%
5 Yearn/a5.0%-0.8%19.7%3.3%

Price Volatility Vs. Market

How volatile is Thomson Medical Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Thomson Medical Group undervalued compared to its fair value and its price relative to the market?

2950x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 3H5 (€0.04) is trading above our estimate of fair value (€0.03)

Significantly Below Fair Value: 3H5 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 3H5 is poor value based on its PE Ratio (2950x) compared to the Healthcare industry average (39.9x).

PE vs Market: 3H5 is poor value based on its PE Ratio (2950x) compared to the German market (20.8x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 3H5's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 3H5 is overvalued based on its PB Ratio (2.7x) compared to the DE Healthcare industry average (1.5x).


Next Steps

Future Growth

How is Thomson Medical Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

10.3%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Thomson Medical Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Thomson Medical Group performed over the past 5 years?

-47.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 3H5 has high quality earnings.

Growing Profit Margin: 3H5's current net profit margins (0.2%) are lower than last year (5%).


Past Earnings Growth Analysis

Earnings Trend: 3H5's earnings have declined by -47.5% per year over the past 5 years.

Accelerating Growth: 3H5's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 3H5 had negative earnings growth (-95%) over the past year, making it difficult to compare to the Healthcare industry average (-7.1%).


Return on Equity

High ROE: 3H5's Return on Equity (0.5%) is considered low.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Thomson Medical Group's financial position?


Financial Position Analysis

Short Term Liabilities: 3H5's short term assets (SGD284.2M) exceed its short term liabilities (SGD95.8M).

Long Term Liabilities: 3H5's short term assets (SGD284.2M) do not cover its long term liabilities (SGD585.5M).


Debt to Equity History and Analysis

Debt Level: 3H5's debt to equity ratio (87.7%) is considered high.

Reducing Debt: Insufficient data to determine if 3H5's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 3H5's debt is not well covered by operating cash flow (11.8%).

Interest Coverage: 3H5's interest payments on its debt are not well covered by EBIT (1.7x coverage).


Balance Sheet

Inventory Level: 3H5 has a high level of physical assets or inventory.

Debt Coverage by Assets: 3H5's debt is not covered by short term assets (assets are 0.5x debt).


Next Steps

Dividend

What is Thomson Medical Group's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.3%markettop25%3.6%industryaverage1.8%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate 3H5's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 3H5's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 3H5's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 3H5's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 3H5's dividend in 3 years as they are not forecast to pay a notable one for the German market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.2yrs

Average management tenure


CEO

Chiang Yin Wong (51yo)

0

Dr. Chiang Yin Wong has been Executive Director and Group Chief Executive Officer of Thomson Medical Group Limited since February 1, 2020. He serves as an Independent Director of RHT Health Trust Manager P ...


Leadership Team

NamePositionTenureCompensationOwnership
Chiang Yin Wong
Group CEO & Executive Director0yrsno datano data
Wilson Sam
Executive Director & Group CFO0.9yrsno datano data
Zing Tan
Chief Risk Officer & Director of Group Finance0.9yrsno datano data
Chee Kien Seah
Managing Director of RSP Architecture & Design0yrsno datano data
Teo Yann
Managing Director of Squire Mech Mechanical & Electrical Engineering0yrsno datano data
Swee Chiew Beh
Managing Director of RSP Civil & Structural Engineering0yrsno datano data
Yu Wong
Group Chief Financial Officer of TMC Life Sciences Berhad0yrsno datano data
Foo Soon Soo
Joint Secretary1.4yrsno datano data
Lim Hoi Leong
Joint Secretary1.4yrsno datano data
Wan Binti Wan Mohd Abdullah Yaakob
Group CEO of TMC Life Sciences Berhad & CEO of Thomson Hospital Kota Damansara0yrsno datano data

1.2yrs

Average Tenure

46yo

Average Age

Experienced Management: 3H5's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Chiang Yin Wong
Group CEO & Executive Director0yrsno datano data
Wilson Sam
Executive Director & Group CFO0.9yrsno datano data
Ser Miang Ng
Non-Executive Independent Chairman4.2yrsno data0.059% SGD606.6k
Pang Ong
Independent Director4.1yrsno data0.057% SGD583.2k
Kim Heng
Non-Executive Non-Independent Director1.8yrsno datano data
Wee Lim
Non-Executive & Non-Independent Director0.9yrsno datano data
Lee Lam
Independent Non-Executive Director0.8yrsno datano data

1.4yrs

Average Tenure

59yo

Average Age

Experienced Board: 3H5's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Thomson Medical Group Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Thomson Medical Group Limited
  • Ticker: 3H5
  • Exchange: DB
  • Founded: 1979
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: S$1.560b
  • Listing Market Cap: S$1.028b
  • Shares outstanding: 26.44b
  • Website: https://www.thomsonmedicalgroup.com

Number of Employees


Location

  • Thomson Medical Group Limited
  • 101 Thomson Road, No. 20-04/05
  • United Square
  • Singapore
  • 307591
  • Singapore

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
A50SGX (Singapore Exchange)YesOrdinary SharesSGSGDApr 2018
3H5DB (Deutsche Boerse AG)YesOrdinary SharesDEEURApr 2018

Biography

Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore, Malaysia, the United Kingdom, China, the Middle East, and internationally. The company owns and operates the Thomson Medical Center, as well as a network of 35 clinics and centers, which provide services in the areas of obstetrics, gynecology, pediatrics, aesthetics, cardiology, sports medicine, dermatology, cancer treatment, dental, traditional Chinese medicine, health screening, laboratory, and radiology; and offer diagnostic imaging, pharmacy, and outpatient services. It also provides consumer products and services, such as health supplements, skin care products, and mother and baby products. In addition, the company operates a pre-natal and clinical diagnostic laboratory; the Thomson Hospital Kota Damansara, a 205-bed hospital located in Kota Damansara, Kuala Lumpur; 6 fertility treatment centers under the TMC Fertility Center name; and the Vantage Bay Healthcare City, an integrated health and wellness development that consists of medical, wellness, and educational facilities located in Iskandar Malaysia. Further, it provides architect, planning, and engineering; research and development; property development; and engineering consultancy services. The company was founded in 1979 and is headquartered in Singapore. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/02/23 00:36
End of Day Share Price2020/02/21 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.